Mwanzo4568 • TYO
add
Daiichi Sankyo Co Ltd
Bei iliyotangulia
¥ 4,550.00
Bei za siku
¥ 4,565.00 - ¥ 4,669.00
Bei za mwaka
¥ 3,805.00 - ¥ 6,257.00
Thamani ya kampuni katika soko
9.12T JPY
Wastani wa hisa zilizouzwa
5.36M
Uwiano wa bei na mapato
35.47
Mgao wa faida
1.29%
Ubadilishanaji wa msingi
TYO
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (JPY) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 446.55B | 18.92% |
Matumizi ya uendeshaji wa biashara | 254.60B | 10.82% |
Mapato halisi | 61.29B | 53.26% |
Kiwango cha faida halisi | 13.73 | 28.92% |
Mapato kwa kila hisa | — | — |
EBITDA | 110.60B | 69.06% |
Asilimia ya kodi ya mapato | 25.60% | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (JPY) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 707.67B | 19.79% |
Jumla ya mali | 3.30T | 24.46% |
Jumla ya dhima | 1.67T | 58.69% |
Jumla ya hisa | 1.62T | — |
hisa zilizosalia | 1.90B | — |
Uwiano wa bei na thamani | 5.32 | — |
Faida inayotokana na mali | 6.97% | — |
Faida inayotokana mtaji | 13.24% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (JPY) | Sep 2024info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 61.29B | 53.26% |
Pesa kutokana na shughuli | 33.49B | 284.55% |
Pesa kutokana na uwekezaji | -10.87B | -108.72% |
Pesa kutokana na ufadhili | -78.62B | -75.67% |
Mabadiliko halisi ya pesa taslimu | -97.59B | -237.26% |
Mtiririko huru wa pesa | 53.27B | -46.31% |
Kuhusu
Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,278 billion in revenue in 2022. The company owns the American pharmaceutical company American Regent.
Daiichi Sankyo, Inc. began operating in the U.S. in 2006. It is the U.S. subsidiary of Daiichi Sankyo Company, Limited, and a member of the Daiichi Sankyo Group. The organization, which includes U.S. commercial operations and global clinical development, is headquartered in Basking Ridge, New Jersey.
Daiichi Sankyo Europe, GmbH, the European subsidiary, is headquartered in Munich, Germany. The organization is responsible for development and manufacturing for 12 European countries.
Daiichi Sankyo Company, Limited is a full member of the European Federation of Pharmaceutical Industries and Associations and of the International Federation of Pharmaceutical Manufacturers and Associations. Wikipedia
Afisa Mkuu Mtendaji (CEO)
Ilianzishwa
28 Sep 2005
Makao Makuu
Tovuti
Wafanyakazi
18,726
